‘Mission COVID Suraksha’: Govt mulls mission with Rs 3,000-crore corpus for development, manufacture of Covid-19 vaccine

Financial  Express
August 24, 2020

The proposed mission that will focus on end-to-end vaccine development from clinical trial stage to regulatory facilitation to manufacturing, will be piloted by the Department of Biotechnology, the PTI report stated.
There is no official word on it as yet, but senior officials told PTI that it is in “a proposal stage”.
As per the draft proposal, the Mission COVID Suraksha is proposed to have a timeline of 12-18 months and a budget of approximately Rs 3,000 crore.

It will also look at ensuring that sufficient volumes of the vaccine are manufactured to meet India’s COVID-19 vaccine requirement.
Also, as per the approval of the National Technical Advisory Group on Immunisation (NTAGI), the mission will focus on efficient ways to introduce the vaccine in public health systems of the Ministry of Health post to combat further spread of COVID-19 infection.
The draft proposal says that it is imperative that the vaccine development and manufacturing now be taken up “in a mission mode and not in a project mode”, the report added.
The national mission will also work towards the development of the COVID vaccine with a focus on ‘AatmaNirbhar Bharat’ and also fulfill the commitment of serving not just the country but the entire globe, the report summed up.


Comments

Popular posts from this blog

ED tracks Swiss Bank A/Cs of Agusta scamster

J&K Cricket Board Scam: Chargesheet Filed Against Farooq Abdullah, 3 Others By CBI

As financial insecurity rises in urban India, so does investment in insurance